Plasma cell mucositis (PCM) is a rare benign proliferative disorder affecting various mucosal surfaces usually seen in elderly patients. In the present case, a 13-year-old young boy reported with the complaint of swollen upper lip and enlarged gums in relation to upper front teeth. The diagnosis of plasma cell mucositis is complex and frequently requires histopathological examination and immunohistochemistry. Management included conventional gingivectomy and intralesional steroid. Regular follow-up of PCM is essential based on the possibility of recurrence, the potential involvement of other mucosal surfaces and unknown potential for malignant transformation.
INTRODUCTION
P lasma cell mucositis (PCM) is a benign inflammatory condition characterized by dense plasma cell infiltrate in the mucosa close to the orifices. PCM was first reported by Zoon [1] as involving glans penis. It can affect vulva, lips, buccal mucosa, palate, gingiva, tongue, epiglottis, larynx, and also other parts of the body. The other nomenclatures used for PCM are plasma cell orificial mucositis, idiopathic plasmacytosis, and oral papillary plasmacytosis. [2] According to Smith et al., [3] PCM has been proposed as a name to facilitate the documentation of such cases. PCM is an extremely rare condition, with less than 50 cases reported. [4] A review by Solomon et al., [2] on PCM reported that the average age of affected patients as 56.6 years with a slight male predominance of 1.2:1 and the youngest patient as 27-year-old. Here, we report a case of plasma cell infiltration of gums and labial mucosa in a 13-year-old boy.
CASE REPORT
A 13-year-old, 40 kg male patient reported to the department of periodontics, Mar Baselios Dental College, Kothamangalam, Kerala with the chief complaint of swollen and bleeding gums in upper anterior region. The patient first noticed a mild swelling of the upper lip around six months back with the gradual involvement of the gums, which showed bleeding since the last one month. No contributory medical or dental history could be elicited.
On extraoral examination, the upper lip was swollen and soft in consistency [ Figure 1 ].
Intraoral examination showed a grade II [5] gingival enlargement in relation to the labial aspect of maxillary anteriors [ Figure 2 ]. The gingiva was erythematous and soft in consistency with pseudo pockets measuring 4-5 mm and presented a granular surface. Based on the clinical findings, a differential diagnosis inclusive of inflammatory gingival enlargement with cheilitis, orofacial granulomatosis, tuberculous gingivitis, leukemia, and sarcoidosis was made.
Accordingly, relevant investigations were performed including panoramic radiographs, blood examination, biochemical screening, liver, kidney and thyroid function tests, patch test, chest radiograph and ultrasonography of abdomen, the results of which were found to be within normal limits. Histopathological examination of an incisional biopsy taken from upper labial mucosa showed inflammatory cell infiltrate comprised of plasma cells suggesting a provisional diagnosis of PCM.
As the initial phase of treatment, thorough oral prophylaxis was carried out. Intra 
DISCUSSION
PCM is a rare variation of mucositis comprising of a polyclonal plasma cell infiltration of the mucosa. The coexistence of autoimmune or immunologically mediated diseases is not rare with PCM. [6] However, these diseases are not present in all cases, and no single disease is consistently associated. Kaur et al., [7] reported a similar case in a 47-year-old male with diffuse swelling of gingiva and upper lip. Here, the patient was much younger. PCM is idiopathic and chronic in onset. [8] Numerous theories have been discussed from hypersensitivity reaction to chewing gum, cinnamon or other foreign substances as etiology but none proven to be conclusive. [9] Secondary complications such as subglottic stricture, stenosis, and respiratory obstructions have been reported infrequently with PCM involving trachea and bronchi. [4] PCM is generally considered to be a benign condition, which shows favorable prognosis.
[10] The identification of monoclonal or polyclonal expansion can help in the differential diagnosis of various plasma cell disorders. The confirmation of PCM requires IHC showing polyclonal expression with kappa and lambda chain restrictions other than clinical and histopathological investigations. [3] Kappa and Lambda are immunoglobulin free light chains which are considered as a marker for plasma cell activation. PCM shows a predominance of kappa chain expression than lambda.
[11] Monoclonal proliferations of plasma cells are seen in neoplasms such as multiple myeloma and extramedullary plasmacytoma. The presentation of PCM complicated by evidence of monoclonal proliferation of plasma cells has been reported. [2] However, the potential for full malignant transformation is unknown.
Management of PCM is mainly targeted at symptomatic relief. PCM has been treated with topical, intralesional, and systemic steroids, antibiotics, antifungals, and cryotherapy. Corticosteroid is considered as the most frequent treatment modality, but this has unreliable results and is of questionable benefit. [4] Majority of these results in disease stabilization but complete regression is rarely noticed. Even though a rare entity, the clinical and histological features of PCM may resemble many common benign and neoplastic conditions of oral cavity and hence it is a diagnosis of exclusion requiring extensive investigation and multidisciplinary evaluation.
CONCLUSION
PCM is rarely reported in dental literature, and it is important to recognize PCM in dental community. The diagnosis is based on clinical pathologic correlation, and therefore, close communication between specialists in several disciplines are required for proper diagnosis of such rare disorder. Documentation and reporting of such cases with regular follow-up will bring greater awareness of the condition and can be helpful in identifying the condition at a younger age to prevent future complications.
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